1 / 1

Presently, over 240 ADC therapy candidates are being evaluated in clinical by roots analysis.

With six marketed drugs, ADCs are presently recognized as a potent class of targeted anticancer therapies, with the potential to be used to treat a variety of other disease indications. The success of such products can be attributed to their ability to effectively identify and eliminate disease associated cells / pathogens, with substantially lower risk of treatment related side effects.<br> <br>To order this 600 page report, which features 190 figures and 280 tables, please visit this Antibody Drug Conjugates Market (5th Edition), 2019-2030.<br>

kevin987
Download Presentation

Presently, over 240 ADC therapy candidates are being evaluated in clinical by roots analysis.

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    More Related